EP Patent

EP1275373A4 — Drug delivery system for avoiding pharmacokinetic interaction between drugs and method thereof

Assigned to Astellas Pharma Inc · Expires 2007-04-04 · 19y expired

What this patent protects

A system for avoiding an unfavorable pharmacokinetic interaction between a drug and another concomitant drug which comprises controlling the release time and/or release site of the drug and/or the concomitant drug in the body.

USPTO Abstract

A system for avoiding an unfavorable pharmacokinetic interaction between a drug and another concomitant drug which comprises controlling the release time and/or release site of the drug and/or the concomitant drug in the body.

Drugs covered by this patent

Patent Metadata

Patent number: EP1275373A4
Jurisdiction: EP
Classification: —
Expires: 2007-04-04
Drug substance claim: No
Drug product claim: No
Assignee: Astellas Pharma Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.